Uncategorized
NovaBay Pharmaceuticals Reports 2015 First Quarter Financial Results and Provides Business Update
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today reported financial results for the three months ended March 31, 2015, and provided a business update. First Quarter 2015 and Recent Operational and Financial Highlights Grew sales of Avenova™ by 112% to $465,000 in the first quarter of 2015 over the fourth quarter of 201
